Speaker Profile
Vice President of Marketing, Pharma & Therapeutic Areas, Labcorp
Biography
Maggie joined Labcorp in 2022 through our acquisition of Personal Genome Diagnostics Inc. (PGDx)where she was Head of Marketing and Commercial Strategy. Since joining Labcorp, Maggie has served asthe Head of Oncology marketing with responsibility for leading our gotomarket efforts for Oncologydrug development, Diagnostics as well as Cell and Gene Therapy. As a veteran of the genomics industry, Maggie is passionate about empowering teams to deliver innovative, highly differentiated solutions to market that can improve the human condition. Prior to PGDx, Maggie served as Head, Oncology Product Management and Strategy at Invitae (NVTA), having joined Invitae through the acquisition of ArcherDX, where she served as Executive Vice President, Commercial Operations. Maggie also held sales and marketing leadership roles supporting academic, government, pharma and clinical markets for Agilent Technologies (A), Advanced Cell Diagnostics, Cogenics, Incyte Genomics (INCY) and Stratagene.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2024 Award Ceremony:
Luminary Honoree: Catriona Jamieson, UCSD Health
- Keynote: Targeting Cancer Stem Cells in Precision Oncology
- Catriona Jamieson, UCSD Health
- Revolutionizing Clinical Trials: Precision Oncology and Novel Trial Designs (PANEL)
Chair: Razelle Kurzrock, MCW
- Vivek Subbiah, Sarah Cannon Research Institute (SCRI)
- Andrea Cercek, Memorial Sloan Kettering
- Ben George, MCW
- Patricia LoRusso, Yale - Transcriptomics in Precision Oncology: Opportunities and Limitations (PANEL)
Chair: Razelle Kurzrock, MCW
- Charles Perou, University of North Carolina
- Eytan Ruppin, NIH
- Bruce Quinn, Bruce Quinn Assoc LL
- Legislation Mandating Insurance Coverage for Biomarker Testing
- Kathryn Phillips, UCSF
- Collaborative Frontiers: Transforming Cancer Care Access and Patient Outcomes (PANEL)
Chair: Maggie Rougier-Chapman, Labcorp
- Exploring the Clinical Utility of Dynamic ctDNA Monitoring
Chair: Lincoln Pasquina, Foundation Medicine
- Hatim Husain, UCSD - Antibody-Drug Conjugates (ADCs): Tracing the Evolution and Forecasting the Future (PANEL)
Chair: Adrian Lee, UPMC
- Sandhya Girish, Gilead
- Neelima Denduluri, Astra Zeneca
- Hope S. Rugo, UCSF - PMWC Showcase
- Michael Milburn, Genecentric Tx
- Matthew Goldberg, Castle Bio
- NCI Showcase
- Nick Reder, Alpenglow Bio
